Physician profile
Seth D Cohen
NPI 1548295306
$2,897.09
in general payments reported to CMS, 2019-2025
38 companies · $873 in 2025
The $873 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2020: $305 · 2021: $67.17 · 2022: $26.69 · 2023: $245 · 2024: $526 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.88 |
| Education | $120.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $392.11 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $328.71 | 2019-2025 | Opdivo, Opdualag |
| Pfizer INC. | $268.31 | 2019-2025 | |
| Daiichi Sankyo INC. | $203.75 | 2024-2025 | Enhertu, Vanflyta, Injectafer |
| Cook Medical LLC | $154.28 | 2023 | Resonance |
| Genentech USA, INC. | $137.53 | 2019-2024 | Phesgo |
| Merck Sharp & Dohme LLC | $133.78 | 2019-2023 | Keytruda |
| Seagen INC. | $128.77 | 2019-2020 | |
| Janssen Biotech, INC. | $119.12 | 2019 | |
| Eisai INC. | $112.43 | 2019-2025 | |
| Gilead Sciences, INC. | $107.24 | 2021-2025 | Trodelvy |
| Celgene Corporation | $87.70 | 2020-2025 | Reblozyl |
| Exelixis INC. | $71.62 | 2019-2024 | Cabometyx |
| Astellas Pharma US INC | $69.23 | 2019-2025 | Vyloy |
| Abbvie INC. | $54.72 | 2019-2025 |
Show all 37 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.